Back to search

Article

A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challenge

2022-12-19

Abstract excerpt

Monkeypox virus (MPXV) caused a global outbreak in 2022, fueled by behaviorally-altered and enhanced human-to-human transmission. While smallpox vaccines were rapidly deployed to curb spread and disease among those at highest risk, breakthrough disease was noted after complete immunization. Given the imminent threat of additional zoonotic events as well as the virus’ evolving ability to drive human-to-human transm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6ccb4971-d8be-527e-bb70-8c6072c2a18a
DOI
10.1101/2022.12.17.520886
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challengeDOI 10.1101/2022.12.17.520886
Select a neighboring publication to make it the new centre.